Skip to main content
MEK inhibitors as therapeutic agents and diagnostic tools for hemoglobinopathies, including thalassemia

MEK inhibitors as therapeutic agents and diagnostic tools for hemoglobinopathies, including thalassemia

Value Proposition Patients with sickle cell disease experience acute vaso-occlusive “crises”, which lead to significant pain, multiple organ damage, and eventually organ failure. Such crises are caused largely by their abnormal sickle red blood cells,…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us